NPI Details
SENTRA LABORATORIES INC/ is a clinical medical laboratory in Bay Shore, NY. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. SENTRA LABORATORIES INC/ NPI is 1871953109. The provider is registered as an organization entity type.
The provider's business location address is:
40 BAY SHORE AVE
BAY SHORE, NY
ZIP 11706-929
Phone: (630) 417-7862
The provider's authorized official is Charles Levy .
The authorized official title is President and has the following contact phone number (630) 417-7862.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Dihydroxyvitamin d, 1, 25 level (HCPCS:82652)
- Hemoglobin a1c level (HCPCS:83036)
- Iron level (HCPCS:83540)
- Thyroid hormone, t3 measurement, free (HCPCS:84481)
- Magnesium level (HCPCS:83735)
- Phosphate level (HCPCS:84100)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Ferritin (blood protein) level (HCPCS:82728)
- Iron binding capacity (HCPCS:83550)
- Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
- Automated urinalysis test (HCPCS:81003)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
The enumeration date for this NPI number is 2/29/2016 and was last updated on 6/19/2023.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | PFI# 8899 | NEW YORK | Yes |
